UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Infectious Diseases Peer Reviewers

Elaine J Abrams, MD

Professor of Pediatrics and Epidemiology

Columbia University

Disclosure: Consultant/Advisory Boards: Viiv [Pediatric antiretroviral medications (Dolutegravir, maraviroc)]; Merck [New antiretroviral medications, drug resistance, pediatric applications (Doravirine)].

Ahsan Ali, MD

Professor of Surgery

University of Arkansas for Medical Sciences

Disclosure: Nothing to disclose

Robin K Avery, MD

Visiting Professor

Johns Hopkins Hospital

Disclosure: Grant/Research/Clinical Trial Support: Shire [CMV infection (Maribavir)]; Astellas [CMV infection (CMV vaccine)]; Chimerix [CMV infection (Brincidofovir)]; Merck [CMV infection (Letermovir)]; Oxford Immunotec [CMV infection (Cellular immune assay)]; AiCuris [Herpes simplex virus (Pritelivir)].

Larry M Baddour, MD, FIDSA, FAHA

Professor of Medicine

Mayo Clinic College of Medicine

Disclosure: Other Financial Interest: NEJM Journal Watch Infectious Diseases.

Miriam Baron Barshak, MD

Assistant Professor of Medicine

Harvard Medical School

Disclosure: Equity Ownership/Stock Options: Pfizer; Boston Scientific, Inc.

John G Bartlett, MD

Editor-in-Chief — Infectious Diseases

Section Editor — HIV; Pulmonary Infections

Professor Emeritus

Johns Hopkins University School of Medicine

Disclosure: Nothing to disclose

Francesca Beaman, MD

Division Chief, Musculoskeletal Radiology Program Director, Musculoskeletal Fellowship Assistant Professor Departments of Radiology and Orthopedics & Sports Medicine University of Kentucky

Disclosure: Nothing to disclose

Irmgard Behlau, MD

Director, Infectious Disease Services

Massachusetts Eye and Ear Infirmary

Disclosure: Nothing to disclose

John Bernardo, MD

Professor of Medicine and Research Professor of Biochemistry

Boston University School of Medicine

Disclosure: Nothing to disclose

Brookie M Best, PharmD, MAS

Associate Dean for Admissions and Outreach

Professor of Clinical Pharmacy and Pediatrics

Skaggs School of Pharmacy and Pharmaceutical Sciences

Department of Pediatrics, School of Medicine-Rady Children's Hospital San Diego

Disclosure: Nothing to disclose

P Brandon Bookstaver, PharmD, BCPS (AQ-ID), AAHIVE

Associate Professor, Department of Clinical Pharmacy and Outcomes Sciences

South Carolina College of Pharmacy

Disclosure: Grant/Research Support: Cubist Pharmaceuticals (antimicrobial lock therapy). Speaker's Bureau: Merck (antimicrobial stewardship).

Todd T. Brown, MD, PhD

Associate Professor of Medicine and Epidemiology

Johns Hopkins University

Disclosure: Consultant Advisory Boards: Gilead [HIV (tenofovir, elvitegravir)]; Merck [HIV (raltegravir)]; Theratechnologies [HIV lipo (tesamorelin)]; EMD Serono [HIV lipo (tesamorelin)/ HIV Wasting (growth hormone)]; BMS [HIV (atazanavir]).

Angela M Caliendo, MD, PhD

Executive Vice Chair of Medicine

Brown University

Disclosure: Grant/Research/Clinical Trial Support: Hologic [HIV viral load; HSV; respiratory viruses]; T2 Biosystems [Aspergillus diagnosis]. Consultant/Advisory Boards: Roche Molecular [CMV]; Quidel [Molecular diagnostics for infectious diseases]; Cepheid [CMV]; IDbyDNA [Genomic testing for infectious diseases]; DNAe [Molecular diagnostics for infectious diseases].

Peggy L Carver, PharmD

Associate Professor of Pharmacy

University of Michigan College of Pharmacy

Disclosure: Nothing to disclose

Tracey A Cho, MD, MA

Program Director, Harvard-BWH-MGH Neurology Residency

Director, Neurology Clerkship

Co-Director, Infectious/Autoimmune Neurology Program

Massachusetts General Hospital

Disclosure: Nothing to disclose

David B Clifford, MD

Melba and Forest Seay Professor of Clinical Neuropharmacology in Neurology

Washington University in St. Louis

Departments of Neurology and Medicine

Disclosure: Nothing to disclose

Stan Deresinski, MD

Clinical Professor of Medicine, Division of Infectious Diseases and Geographic Medicine

Stanford University

Disclosure: Nothing to disclose

Scott Dryden-Peterson, MD

Assistant Professor in Medicine

Harvard Medical School

Disclosure: Nothing to disclose

J Stephen Dumler, MD

Professor and Chair

Department of Pathology

Uniformed Services University of the Health Sciences

Walter Reed National Military Medical Center

Joint Pathology Center

Disclosure: Nothing to disclose

Timothy Endy, MD, MPH, FACP, FIDSA, FASTMH

Professor and Chair, Department of Microbiology and Immunology

Vice-Chair for Research, Department

Disclosure: Consultant/Advisory Board: Sanofi-Pasteur [Dengue (vaccine)]; Visterra [Ebola (vaccine)]. Grant/Research/Clinical Trial Support: NIH [Dengue]. Patent Holder: Walter Reid [Zika (vaccine)].

Thomas M File, Jr, MD

Section Editor — Pulmonary Infections

Professor of Medicine

Northeast Ohio Medical University

Disclosure: Grant/Research/Clinical Trial Support: Nabriva [Community-acquired pneumonia (Lefamulin)]. Consultant/Advisory Boards: Allergan [Resistant infections (Ceftazidime-avibactam)]; Medicines Company [Resistant infections (Meropenem-vaborbactam)]; Merck [HAI (Ceftolozane-tazobactam)]; MotifBio [Gram-positive infections (Iclaprim)]; Nabriva [Various infections (Lefamulin and similar agents)]; Paratek [Pneumonia (Omadacycline)]; Pfizer [Vaccines (Prevnar)].

Jay A Fishman, MD

Professor of Medicine

Harvard Medical School

Director, Transplant Infectious Disease and Compromised Host Program

Massachusetts General Hospital

Disclosure: Nothing to disclose

David O Freedman, MD

Professor of Medicine, Division of Infectious Diseases

University of Alabama at Birmingham

Disclosure: Nothing to disclose

Rajesh T Gandhi, MD

Associate Professor of Medicine

Harvard Medical School

Disclosure: Grant/Research/Clinical Trial Support: Gilead [HIV (Tenofovir/emtricitabine/elvitegravir/cobi, Tenofovir/emtricitabine, Tenfovir/emtricitabine/rilpivirine)]; Merck [HIV (Raltegravir)]; Viiv [HIV (Abacavir/lamivudine/dolutegravir, Dolutegravir, Abacavir/lamivudine)].

Anne A Gershon, MD

Professor of Pediatrics

Columbia University College of Physicians and Surgeons

Disclosure: Grant/Research/Clinical Trial Support: Merck [Varicella vaccine safety study, laboratory procedures genotyping (Varicella vaccine)]; NIH [VZV in the enteric nervous system]. Consultant/Advisory Boards: GSK [Subunit zoster vaccine].

Roy M Gulick, MD, MPH

Associate Professor of Medicine

Weill Medical College of Cornell University

Disclosure: Nothing to disclose

Kalpana Gupta, MD, MPH

Professor of Medicine

Boston University School of Medicine

Chief, Infectious Diseases

Boston VA HCS

Disclosure: Consultant/Advisory Boards: Paratek Pharmaceuticals; Melinta Therapeutics; Iterum Therapeutics; Tetraphase Pharmaceuticals; Ocean Spray Inc. [UTI].

H. Hunter Handsfield, MD

Professor Emeritus of Medicine

University of Washington Center for AIDS and STD

Disclosure: Nothing to disclose

Anthony Harris, MD, MPH

Section Editor — Hospital Acquired Infections

Professor of Medicine

University of Maryland School of Medicine

Disclosure: Nothing to disclose

Howard M Heller, MD, MPH

Assistant Clinical Professor of Medicine

Harvard Medical School

Disclosure: Nothing to disclose

Charles B Hicks, MD

University of California, San Diego

Disclosure: Consultant/Advisory Boards: Bristol-Myers Squibb [HIV infection (all antiretroviral agents)]; Gilead [HIV infection (all antiretroviral agents)]; Merck [HIV infection (all antiretroviral agents)]; Janssen [HIV infection (all antiretroviral agents)]; ViiV [HIV infection (all antiretroviral agents)].

Thomas M Hooton, MD

Professor of Medicine

University of Miami Miller School of Medicine

Disclosure: Consultant/Advisory Boards: Cubist [Complicated UTI (Ceftolozane/tazobactam)]; Danone [UTI management (Hydration therapy)]; GSK (Antimicrobial in development); Ocean Spray (Cranberry products); Paratek Pharmaceuticals (Antimicrobial in development). Equity Ownership/Stock Options: Fimbrion Therapeutics [UTI prevention (Development of mannosides)].

Brenna Hughes, MD, MSc

Associate Professor of Obstetrics and Gynecology

Duke University

Disclosure: Nothing to disclose

Noreen A Hynes, MD, MPH, DTM&H

Section Editor — Sexually Transmitted Diseases

Associate Professor of Infectious Diseases; International Health; and Population, Family, and Reproductive Health

Johns Hopkins University Schools of Medicine and Public Health

Disclosure: Nothing to disclose

Michael G Ison, MD, MS

Professor, Divisions of Infectious Diseases and Organ Transplantation

Northwestern University Feinberg School of Medicine

Disclosure: Grant/Research/Clinical Trial Support: Beckman Coulter [CMV (Investigational)]; Gilead [RSV (Investigational)]; Janssen/Johnson & Johnson [Flu (Investigational)]. Consultant/Advisory Boards: Astellas [Transplant]; BioCryst [Flu (Peramivir)]; Celltrion [Flu (Investigational)]; Chimerix [Adenovirus (Brincidofovir)]; Farmark [Influenza (Investigational)]; Genentech/Roche [Flu (Oseltamivir)]; GlaxoSmithKlein [Flu (Zanamivir)]; NexBio [Flu, PIV (FluDase)]; Romark [Flu (Nitazoxanide)]; Seqirus [Flu (Peramivir)]; Shionogi [Flu (Peramivir)]; Theraclone [Flu (Investigational)]; Toyama/MediVector [Flu (Favirpirivair)]; Unither Virology [Flu (Investigational)].

W. Ray Kim, MD

Professor of Medicine, Gastroenterology and Hepatology

Stanford University Medical Center

Disclosure: Consultant/Advisory Boards: Gilead [Hepatitis (Tenofovir)].

Amy D Klion, MD

Baltimore, MD

Disclosure: Nothing to disclose

Keith P Klugman, MD, PhD

Director for Pneumonia, Bill & Melinda Gates Foundation

William H Foege Professor of Global Health

Disclosure: Nothing to disclose

Marin H Kollef, MD

Professor of Medicine

Washington University School of Medicine

Disclosure: Consultant/Advisory Boards: Accelerate [Diagnostics (Automated microscopy)].

Michael J Kozal, MD

Professor of Medicine

Yale University School of Medicine

Disclosure: Grant/Research Support: Abbvie, Pfizer, Gilead, Hologic, Glaxo/ViiV, CytoDyn, TiaMed, Bristol-Myers Squibb [HIV, Hepatitis C (ART therapy; HIV/HCV/HSV diagnostics)]. Patent Holder: Stanford University [HIV genotyping (HIV genotypic resistance tests)]

Raphael J Landovitz, MD, MSc

Ronald Reagan UCLA Medical Center

UCLA Medical Center, Santa Monica

Disclosure: Grant/Research/Clinical Trial Support: Gilead Sciences [HIV prevention (Tenofovir/emtricitabine)]. Consultant/Advisory Boards: Gilead Sciences [HIV prevention (Tenofovir/emtricitabine)].

Franklin D Lowy, MD

Professor of Medicine and Pathology & Cell Biology (in Epidemiology)

Columbia University, College of Physicians and Surgeons

Disclosure: Grant/Research/Clinical Trial Support: Theravance [Osteomyelitis (Telavancin)]. Patent Holder: Columbia University [Protein SdrF (S epidermidis molecule)].

Lauri Markowitz, MD

Centers for Disease Control and Prevention

Disclosure: Nothing to disclose

Kieren A Marr, MD

Section Editor — Compromised Host Infections; Fungal Infections

Professor of Medicine and Oncology

Johns Hopkins University School of Medicine

Disclosure: Grant/Research/Clinical Trial Support: Merck [Antifungals, fungal infections (caspofungin, posaconazole)]. Consultant/Advisory Boards: Advaxis (Antifungals); Amplyx (antifungals); Astellas [Antifungals, fungal infections (Liposomal amphotericin B, micafungin, isavuconazole)]; Chimerix Therapeutics [Viral infections (Brincidofivir)]; Cidara Therapeutics [Antifungals, fungal infections]; F2G [Antifungals]; [Infections]; Incyte Therapeutics (oncology); Matinas (antimicrobials); Merck [Antifungals, viral infections (Caspofungin, posaconazole)]; Scynexis (antifungals); Theravance Biopharma [Bacterial infections, fever during neutropenia (Telavancin)]; Vical (Antifungals). Patent Holder: MycoMed Technologies [Diagnostics, antifungals (Fungal diagnostics)]. Equity Ownership/Stock Options: MycoMed Technologies [Fungal diagnostics].

Jeanne Marrazzo, MD, MPH, FACP, FIDSA

Professor and Chief, Division of Infectious Diseases

University of Alabama at Birmingham School of Medicine

Disclosure: Grant/Research/Clinical Trial Support: Entasis [Gonorrhea treatment (Investigational drug)]; Cepheid [STD diagnosis (Investigational drug)]; GenProbe/Hologics [STD diagnosis (Investigational drug)].

Thomas J Marrie, MD

Dean Emeritus

Professor of Medicine

Dalhousie University

Disclosure: Nothing to disclose

Christopher McCoy, PharmD, BCPS

Clinical Pharmacy Coordinator: Antimicrobial Stewardship

PGY2 Residency Program Director: Antimicrobial Stewardship

Beth Israel Deaconess Medical Center

Disclosure: Grant/Research/Clinical Trial Support: Zavante [Antibacterials (Fosfomycin IV)]. Consultant/Advisory Boards: Merck [Antimicrobial stewardship (Ertapenem, ceftolozane, tazobactam)].

Malcolm McDonald, PhD, FRACP, FRCPA

Associate Professor

School of Medicine and Dentistry, James Cook University

Disclosure: Nothing to disclose

Kenneth McIntosh, MD

Professor of Pediatrics

Harvard Medical School

Disclosure: Nothing to disclose

John F Modlin, MD

Deputy Director, Polio Research

Global Development

Bill and Melinda Gates Foundation

Disclosure: Nothing to disclose

Kenrad Nelson, MD

Professor

Infectious Disease Epidemiology

Bloomberg School of Public Health

Johns Hopkins University

Disclosure: Nothing to disclose

Ntobeko Ntusi, BSc(hons) MBChB FCP(SA) D.Phil

Faculty of Health Sciences

Division of Cardiology

Department of Medicine

University of Cape Town

Disclosure: Nothing to disclose

Ina Park, MD, MS

Associate Professor

Department of Family and Community Medicine

UCSF School of Medicine

Disclosure: Nothing to disclose

Robin Patel, MD

Professor of Microbiology and Medicine

Mayo Clinic

Disclosure: Grant/Research/Clinical Trial Support: CD Diagnostics; BioFire; Curetis; Merck; Hutchison Biofilm Medical Solutions; Accelerate Diagnostics; Allergan; The Medicines Company [Diagnostics, anti-infectives (Ceftazidime-avibactam, ceftolozane-tazobactam, dalbavancin, oritavancin, tedizolid)]. Consultant/Advisory Boards: Curetis [Dianostics]. Patent Holder: Bordetella pertussis/parapertussis PCR; Samsung [Sonication (device/method)]; Anti-biofilm substance.

Thomas F Patterson, MD, FACP, FIDSA

Chief, Division of Infectious Diseases

Professor of Medicine

Director, San Antonio Center for Medical Mycology

The University of Texas Health Science Center at San Antonio

Disclosure: Consultant/Advisory Boards: Astellas [Antifungals (Isavuconazole, micafungin, liposomal amphotericin B)]; Basilea [Antifungals (Isavuconazole)]; Gilead [Antifungals (Liposomal amphotericin B)]; Merck [Antifungals (Posaconazole, caspofungin)]; Scynexis [Antifungals]; Toyama [Antifungals].

Elizabeth J Phillips, MD, FRCPC, FRACP, FIDSA, FAAAAI

Professor of Medicine & Pharmacology

John A. Oates Chair in Clinical Research

Vanderbilt University Medical Center

Institute for Immunology & Infectious Diseases

Disclosure: Nothing to disclose

Michael E Pichichero, MD

Director, Research Institute

Rochester General Hospital

Disclosure: Nothing to disclose

Laurie Proia, MD

Associate Professor of Medicine

Rush Medical College

Disclosure: Nothing to disclose

Karen M Puopolo, MD, PhD

Associate Professor of Clinical Pediatrics

University of Pennsylvania Perelman School of Medicine

Disclosure: Nothing to disclose

Laura E Riley, MD

Assistant Professor of Obstetrics, Gynecology and Reproductive Biology

Harvard Medical School

Disclosure: Nothing to disclose

Edward T Ryan, MD, DTMH

Section Editor — Parasitic Infections

Professor of Medicine

Harvard Medical School

Disclosure: Consultant/Advisory Boards: Becton Dickinson [Fever diagnostic].

George Sakoulas, MD

Associate Professor

University of California San Diego School of Medicine

Disclosure: Speaker’s Bureau: The Medicines Company [Anti-infectives (oritavancin)]; Allergan [Anti-infectives (ceftaroline, dalbavancin)]. Consultant/Advisory Boards: The Medicines Company [Anti-infectives (oritavancin)]; Allergan [Anti-infectives (ceftaroline, dalbavancin)].

Paul E Sax, MD

Section Editor — HIV

Clinical Director, Division of Infectious Diseases

Brigham and Women's Hospital

Professor of Medicine

Harvard Medical School

Disclosure: Grant/Research/Clinical Trial Support: Gilead Sciences [HIV (tenofovir, emtricitabine, elvitegravir, cobicistat, ledipasvir, sofosbuvir)]; GlaxoSmithKline [HIV (lamivudine, abacavir, dolutegravir)]. Consultant/Advisory Boards: AbbVie [HIV (lopinavir, ritonavir)]; Bristol-Myers Squibb [HIV (atazanavir, efavirenz)]; Gilead Sciences [HIV (tenofovir, emtricitabine, elvitegravir, cobicistat, ledipasvir, sofosbuvir)]; GlaxoSmithKline [HIV (lamivudine, abacavir, dolutegravir)]; Janssen Pharmaceuticals [HIV (darunavir, etravirine, rilpivirine)]; Merck & Co, Inc. [HIV (raltegravir)].

John S Schieffelin, MD, MSPH

Assistant Professor of Clinical Pediatrics and Internal Medicine

Tulane University School of Medicine

Disclosure: Nothing to disclose

Cynthia L Sears, MD

Professor of Medicine

Johns Hopkins University School of Medicine

Disclosure: Consultant/Advisory Boards: Bristol Myers Squibb [Microbiome research]. Other Financial Interest: Abbvie [Microbiome in human health].

Daniel J Sexton, MD

Editor-in-Chief — Infectious Diseases

Section Editor — Bacterial Infections

Professor of Medicine

Duke University Medical Center

Disclosure: Grant/Research/Clinical Trial Support: Centers for Disease Control and Prevention; National Institutes of Health [Healthcare epidemiology]. Consultant/Advisory Boards: Sterilis [Medical waste disposal]. Equity Ownership/Stock Options: Magnolia Medical Technologies [Medical diagnostics (Blood culture techniques)]. Other Financial Interest: Johnson & Johnson [Mesh-related infections].

Eugene D Shapiro, MD, FAAP

Professor of Pediatrics, Epidemiology, and Public Health and Investigative Medicine

Yale University School of Medicine

Disclosure: Nothing to disclose

Kenneth E Sherman, MD, PhD

Professor of Medicine

University of Cincinnati College of Medicine

Disclosure: Grant/Research Support: AbbVie; BMS; Gilead; Merck; Medimmune; Innovio [HCV, HBV]. Consultant/Advisory Boards: Merck; Medimmune; ViiV [HCV, HBV]. Other Financial Interest: DSMB: MedPace; SynteractHCR [NASH, HCV].

Jihad Slim, MD

Assistant Professor

Seton Hall School of Health and Medical Sciences

Disclosure: Grant/Research/Clinical Trial Support: Gilead, ViiV [HIV-HCV coinfection (Sofosbuvir, ledipasvir, dolutegravir)]. Speaker’s Bureau: Gilead, Abbvie, BMS, Jansen [HCV therapy (Sofosbuvir, ledipasvir, daclatasvir, simepravir, Viekira pack)].

Jack D Sobel, MD

Professor

Wayne State University School of Medicine

Disclosure: Nothing to disclose

Denis Spelman, MBBS, FRACP, FRCPA, MPH

Adjunct Professor, Monash University

Alfred Hospital, Victoria, Australia

Disclosure: Nothing to disclose

Iain Stephenson, MD, FRCP

Senior Lecturer in Infectious Diseases

University Hospitals of Leicester, UK

Disclosure: Nothing to disclose

Timothy R Sterling, MD

Professor of Medicine

Vanderbilt University School of Medicine

Disclosure: Nothing to disclose

Jason Stout, MD

Associate Professor of Medicine

Duke University Medical Center

Disclosure: Nothing to disclose

Elizabeth A Talbot, MD

Associate Professor of Medicine

Geisel School of Medicine at Dartmouth

Disclosure: Consultant/Advisory Boards: Oxford Immunotec [Tuberculosis (Interferon-gamma release assay)].

Lynn E Taylor, MD

Assistant Professor of Medicine

The Warren Alpert Medical School of Brown University

Disclosure: Nothing to disclose

Chloe L Thio, MD

Professor of Medicine

Johns Hopkins University

Disclosure: Grant/Research/Clinical Trial Support: Gilead Sciences [Hepatitis (Tenofovir disoproxil fumarate, tenofovir alafenamide)].

David L Thomas, MD

Section Editor — Hepatitis/HIV Coinfection

Chief, Division of Infectious Diseases

Johns Hopkins University School of Medicine

Disclosure: Consultant/Advisory Boards: Merck.

Phyllis C Tien, MD

Associate Professor of Medicine

University of California, San Francisco

Disclosure: Nothing to disclose

Tram T Tran, MD

Medical Director of Liver Transplantation

Liver Disease and Transplant Center at Cedars-Sinai.

Disclosure: Grant/Research/Clinical Trial Support: Gilead [Tenofovir]. Consultant/Advisory Boards: Gilead [Tenofovir].

Allan R Tunkel, MD, PhD, MACP

Professor of Medicine

Warren Alpert Medical School of Brown University

Disclosure: Nothing to disclose

Anna Wald, MD, MPH

Professor of Medicine, Epidemiology, and Laboratory Medicine

University of Washington

Disclosure: Grant/Research/Clinical Trial Support: Genocea [Herpes simplex virus (HSV therapeutic vaccine)]; Vical [Herpes simplex virus (HSV therapeutic vaccine)]. Consultant/Advisory Boards: AiCuris [Herpes simplex virus (novel antiviral for HSV)]; GSK [Herpes simplex virus (therapeutic HSV vaccine)]; Merck DSMB [Varicella zoster virus (HSV therapeutic vaccine)].

Ellen R Wald, MD

Professor of Pediatrics

University of Wisconsin School of Medicine and Public Health

Disclosure: Nothing to disclose

David H Walker, MD

Professor, Department of Pathology

Carmage and Martha Walls Distinguished University Chair in Tropical Diseases

University of Texas Medical Branch

Disclosure: Nothing to disclose

Mark Waltzman, MD

Assistant Professor of Pediatrics

Harvard Medical School

Disclosure: Nothing to disclose

Robert A Weinstein, MD

The C Anderson Hedberg MD Professor of Internal Medicine

Rush Medical College

Disclosure: Grant/Research/Clinical Trial Support: Sage Inc [Chlorhexidine wipes].

Christopher Whalen, MD, MS

Professor of Epidemiology and Biostatistics

University of Georgia

Disclosure: Nothing to disclose

Rachel L Winer, PhD, MPH

Associate Professor of Epidemiology

University of Washington School of Public Health

Disclosure: Nothing to disclose

Edward J Wing, MD

Professor of Medicine

Warren Alpert Medical School of Brown University

Disclosure: Nothing to disclose

Kevin L Winthrop, MD, MPH

Professor, School of Public Health

Associate Professor, Department of Medicine

Divisions of Infectious Disease and Ophthalmology,

Oregon Health and Sciences University

Disclosure: Grant/Research/Clinical Trial Support: Bristol-Myers Squibb [vaccine]. Consultant/Advisory Boards: Pfizer [Rheumatology (Tofacitinib, etanercept)]; UCB [Rheumatology (Certolizumab); Amgen, Abbvie [Rheumatology (Adalimumab)].

Danielle M Zerr, MD, MPH

Professor, Pediatric Infectious Diseases

University of Washington

Disclosure: Nothing to disclose